Two of the greatest threats to patient health, hypertension (HTN) and heart failure (HF), are discussed in meticulous detail in this second installment of our Comprehensive Cardiovascular Pharmacology series. Beginning with an overview of national and international guidelines in the assessment and staging of HTN, the session then analyzes the most effective pharmacologic treatment pathways for patients with this condition, including those in special populations. Special attention is given to the prevention and treatment of hypertensive crises, including a thorough discussion on the proper administration of vasodilators.
This session then dives into the structural and neurohormonal mechanisms of HF before moving into a review of national staging guidelines for patients with HF. Pharmacologic agents in the treatment of mild to the most severe cases of HF are presented in detail, and before the session closes, an examination of the varying devices in mechanical circulatory support is provided.